We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
(-17%)
Cap. Flow
+$50.1M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$40.1M |
| 2 |
Procter & Gamble
PG
|
+$19.2M |
| 3 |
Merck
MRK
|
+$12.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$10.3M |
| 5 |
IBM
IBM
|
+$9.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$37.9M |
| 2 |
Apple
AAPL
|
+$19.7M |
| 3 |
Microsoft
MSFT
|
+$14.9M |
| 4 |
Home Depot
HD
|
+$14.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.34% |
| 2 | Healthcare | 13.95% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Financials | 10.87% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Pacific Biosciences
PACB
$482M
| $54K | ﹤0.01% |
+12,210
| New | +$74.2K |
|
|
QVCGA
1152
DELISTED
QVC Group Inc Series A
QVCGA
| $54K | ﹤0.01% |
+377
| New | +$73.2K |
|
1153
American Well
AMWL
$200M
| $53K | ﹤0.01% |
+616
| New | +$46K |
|
1154
MannKind Corp
MNKD
$1.31B
| $52K | ﹤0.01% |
13,552
+1,808
| +15% | +$6.64K |
|
|
IMGN
1155
DELISTED
Immunogen Inc
IMGN
| $52K | ﹤0.01% |
11,594
+1,378
| +13% | +$5.99K |
|
1156
Compass
COMP
$8.52B
| $51K | ﹤0.01% |
+14,237
| New | +$77.9K |
|
|
LOGC
1157
DELISTED
ContextLogic
LOGC
| $49K | ﹤0.01% |
+1,020
| New | +$55.2K |
|
1158
Uranium Energy
UEC
$6.74B
| $47K | ﹤0.01% |
15,171
+2,610
| +21% | +$10.9K |
|
1159
Brookdale Senior Living
BKD
$2.89B
| $46K | ﹤0.01% |
+10,129
| New | +$59.8K |
|
1160
Payoneer
PAYO
$2.42B
| $46K | ﹤0.01% |
+11,616
| New | +$51.8K |
|
1161
Coeur Mining
CDE
$22.8B
| $45K | ﹤0.01% |
14,913
+2,764
| +23% | +$10.9K |
|
1162
Globalstar
GSAT
$10.6B
| $45K | ﹤0.01% |
2,452
+522
| +27% | +$9.69K |
|
1163
Clover Health Investments
CLOV
$2.25B
| $44K | ﹤0.01% |
+20,562
| New | +$54.6K |
|
1164
Rocket Lab Corp
RKLB
$43.2B
| $43K | ﹤0.01% |
+11,457
| New | +$67.4K |
|
|
MTTR
1165
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $43K | ﹤0.01% |
+11,881
| New | +$64.9K |
|
|
SRNE
1166
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $41K | ﹤0.01% |
20,288
+6,088
| +43% | +$10.5K |
|
1167
UWM Holdings
UWMC
$2.37B
| $40K | ﹤0.01% |
+11,318
| New | +$43.4K |
|
1168
Paysafe
PSFE
$351M
| $36K | ﹤0.01% |
+1,523
| New | +$49.1K |
|
|
DM
1169
DELISTED
Desktop Metal, Inc.
DM
| $31K | ﹤0.01% |
+1,411
| New | +$41.3K |
|
1170
Geron
GERN
$983M
| $30K | ﹤0.01% |
19,474
+5,138
| +36% | +$7.26K |
|
|
NVTA
1171
DELISTED
Invitae Corporation
NVTA
| $30K | ﹤0.01% |
+12,266
| New | +$54.2K |
|
|
AGEN
1172
Agenus
AGEN
$352M
| $28K | ﹤0.01% |
735
+204
| +38% | +$7.41K |
|
1173
Ocugen
OCGN
$465M
| $26K | ﹤0.01% |
+11,526
| New | +$27.6K |
|
1174
Senseonics Holdings Inc
SENS
$497M
| $26K | ﹤0.01% |
1,242
+214
| +21% | +$5.58K |
|
1175
Gevo
GEVO
$415M
| $25K | ﹤0.01% |
+10,791
| New | +$39.5K |
|
Similar funds
PCM
LPC
CAM
MFG
PAM
BS
BBVA
NMO
Xponance's Q2 2022 Portfolio in Review
As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
- Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
- Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
- Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
- Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
- Xponance opened 93 new positions and closed 68 in Q2 2022.
- Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.
Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.